We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Schistosoma mekongi May Be More Widespread than Previously Thought

By Labmedica staff writers
Posted on 03 Apr 2008
A new genetic analysis suggests that the parasitic worm Schistosoma mekongi is more widespread than previously thought. More...
According to the study, the human population at risk of infection could be up to 10 times greater than estimated. Furthermore, the results of the analysis suggest that there is an increased possibility of the spread of the parasite across Laos and Vietnam.

Before this study, it was assumed that S. mekongi originating in Yunnan, China, migrated southwards across Laos and into Cambodia, and later became extinct in Laos due to conditions unsuitable for transmission. However, investigators Dr. Stephen W. Attwood of China's Sichuan University (Chengdu, China) and colleagues analyzed DNA sequences of sample organisms collected from the Mekong River and its tributaries in Cambodia, Laos, and Malaysia. They found that S. mekongi was confined to a small section of the lower Mekong River, as well as in its tributaries across Cambodia. In addition, the range of the snail intermediate host and the ecologic conditions for potential transmission were shown to be much broader than once thought. The analysis suggested a more recent, and ongoing, migration northwards from Vietnam, towards Cambodia and Laos.

Schistosomiasis, a parasitic disease that affects over 200 million people worldwide, is caused by several flatworm species of the genus Schistosoma. In the Mekong River basin in South-East Asia, the disease is transmitted by the species S. mekongi. A mass treatment program in the mid-1990s greatly reduced the prevalence of the disease.

According to the investigators, further work is required to investigate this problem because if there is no reason to assume that ecologic conditions in Laos are unsuitable for transmission, it is still possible that in the future this disease will spread northward, from Vietnam and Cambodia into Laos.

The study was published in the March 2008 issue of the journal PLoS Neglected Tropical Diseases.


Related Links:
Sichuan University

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Automatic Western Blot Analyzer
Tenfly Phoenix Blot Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.